Immediate Impact

2 by Nobel laureates 22 from Science/Nature 64 standout
Sub-graph 1 of 19

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021 Standout
12 intermediate papers

Works of Melanie Royce being referenced

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
2013
Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012
2011
and 4 more

Author Peers

Author Last Decade Papers Cites
Melanie Royce 1798 1147 684 951 88 3.0k
Deborah Toppmeyer 2209 1215 655 1079 94 3.3k
Alberto Bottini 1617 1446 493 1079 116 3.1k
Florence Lerebours 1365 1179 674 894 96 2.5k
Saranya Chumsri 2042 1011 564 1240 117 3.7k
Giulia Viale 1790 1102 634 800 68 2.9k
Mónica Arnedos 1576 1186 984 1352 90 3.0k
Theodoros Foukakis 2035 1449 694 1411 130 4.0k
Per Malmström 1298 1070 509 989 61 2.6k
Richard B. Schwab 1338 1268 604 1469 85 3.3k
Romano Demicheli 2060 1266 538 701 95 3.3k

All Works

Loading papers...

Rankless by CCL
2026